The present disclosure relates to pharmaceutical compositions of solid dosageform for intraoral administration thatprovides effective delivery of insulin and insulin analogs via thetransmucosal route. Also provided are methods for treatingpre-diabetes, diabetes and metabolic syndrome in a subject in need thereof.